Hamlin Capital Management, LLC has opened a new $160.8M position in $CVS, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CVS.
$CVS Hedge Fund Activity
We have seen 858 institutional investors add shares of $CVS stock to their portfolio, and 832 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 8,398,255 shares (+31.2%) to their portfolio in Q3 2025, for an estimated $633,144,444
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,472,749 shares (+69.0%) to their portfolio in Q3 2025, for an estimated $487,980,547
- WELLINGTON MANAGEMENT GROUP LLP added 5,042,816 shares (+391.6%) to their portfolio in Q3 2025, for an estimated $380,177,898
- CITADEL ADVISORS LLC removed 4,959,383 shares (-60.7%) from their portfolio in Q3 2025, for an estimated $373,887,884
- AMUNDI added 3,637,943 shares (+95.3%) to their portfolio in Q3 2025, for an estimated $274,264,522
- JENNISON ASSOCIATES LLC removed 3,022,874 shares (-75.3%) from their portfolio in Q3 2025, for an estimated $227,894,470
- BLACKROCK, INC. removed 2,850,536 shares (-2.3%) from their portfolio in Q3 2025, for an estimated $214,901,909
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CVS Insider Trading Activity
$CVS insiders have traded $CVS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CVS stock by insiders over the last 6 months:
- ANNE A. FINUCANE sold 7,500 shares for an estimated $532,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CVS Government Contracts
We have seen $7,069,230 of award payments to $CVS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BES...: $5,476,406
- CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BES...: $1,381,573
- PHARMACY REPACKAGING: $200,000
- CVS GIFT CARDS: $11,250
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$CVS Congressional Stock Trading
Members of Congress have traded $CVS stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:
- REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 11/21.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CVS Analyst Ratings
Wall Street analysts have issued reports on $CVS in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/10/2025
- Truist Securities issued a "Buy" rating on 12/10/2025
- Mizuho issued a "Outperform" rating on 12/10/2025
- UBS issued a "Buy" rating on 12/10/2025
- Barclays issued a "Overweight" rating on 12/10/2025
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for $CVS, check out Quiver Quantitative's $CVS forecast page.
$CVS Price Targets
Multiple analysts have issued price targets for $CVS recently. We have seen 15 analysts offer price targets for $CVS in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- Lisa Gill from JP Morgan set a target price of $101.0 on 12/17/2025
- Lance Wilkes from Bernstein set a target price of $87.0 on 12/12/2025
- Jessica Tassan from Piper Sandler set a target price of $101.0 on 12/10/2025
- Erin Wright from Morgan Stanley set a target price of $93.0 on 12/10/2025
- Michael Ha from Baird set a target price of $92.0 on 12/10/2025
- David Macdonald from Truist Securities set a target price of $98.0 on 12/10/2025
- Ann Hynes from Mizuho set a target price of $95.0 on 12/10/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CVS ticker page for more data.
